Sarabia, Dexie Jane M.
HRN: 22-44-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/31/2023
02/07/2023
IV
500mg
Q8
S/P LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes